As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

Ward said it would be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking about the population at risk ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

National rates of uterine rupture in trial of labor after cesarean increased from 0.20% in 2010 to 0.37% in 2022, with an ...

After hours: March 14 at 7:59:07 PM EDT Loading Chart for MRNA ...

This stock can be held in an Investment ISA and an Investment Account ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

BioNTech SE exceeded earnings expectations with strong oncology pipeline development, despite reduced vaccine revenue.

MSD and partner Moderna have started a late-stage trial ... it will be some time before efficacy data is available. Secondary endpoints include overall survival (OS), distant metastasis-free ...

It is a forum where practitioners can share learnings, challenges and develop best practice for respecting human rights. How we process personal data provided or obtained through this website. With ...